Association of the systemic immune-inflammatory index and systemic inflammatory response index with all-cause and cardiovascular mortality in individuals with metabolic inflammatory syndrome
Authors:
Open Access
- 2 June 2025
- journal article
- research article
- Published by Springer Nature in European Journal of Medical Research
- Vol. 30 (1) , 1-16
Abstract
Metabolic inflammatory syndrome (MIS) is a novel concept in integrative healthcare that focuses on addressing metabolic disorders. The systemic immune-inflammatory index (SII) and systemic inflammatory response index (SIRI) are emerging biomarkers derived from blood cell counts. However, their associations with all-cause and cardiovascular mortality remain insufficiently explored. This study utilized data from adult participants in the National Health and Nutrition Examination Survey (NHANES) between 2003 and 2018, all of whom had complete MIS-related data. SII and SIRI values were calculated based on blood test results. Kaplan–Meier survival curves and log-rank tests were employed to compare survival rates across quartiles of SII and SIRI. Weighted Cox proportional hazards regression models were used to evaluate the associations of SII and SIRI with all-cause and cardiovascular mortality. Nonlinear relationships and threshold effects were assessed using restricted cubic splines and segmented regression models. Receiver operating characteristic (ROC) and time-dependent ROC curves were generated to assess the predictive performance of SII and SIRI at various timepoints via area under the curve (AUC) analyses. Subgroup and sensitivity analyses were performed to examine these associations within specific populations. A total of 16,972 participants were included in the analysis. After adjusting for potential confounders, individuals in the highest quartile (Q4) of SII exhibited significantly increased risks of all-cause mortality [hazard ratio (HR): 1.28; 95% confidence interval CI 1.09–1.49; P = 0.002] and cardiovascular mortality (HR: 1.64; 95% CI 1.13–2.39; P = 0.009) compared to those in the lowest quartile (Q1). Similarly, participants in the highest quartile of SIRI demonstrated higher risks of all-cause mortality (HR: 1.56; 95% CI 1.26–1.92; P < 0.001) and cardiovascular mortality (HR: 2.14; 95% CI 1.46–3.13; P < 0.001). Both biomarkers emerged as independent predictors of mortality risk. J-shaped dose–response relationships were observed between log-SII and log-SIRI and the risks of all-cause and cardiovascular mortality (all P values for non-linearity were < 0.001). Both ROC and time-dependent ROC curve analyses indicated that log-SIRI had better prognostic performance for all-cause and cardiovascular mortality compared to log-SII. These findings were robust across subgroup and sensitivity analyses. High levels of SII and SIRI were independently associated with increased risks of all-cause and cardiovascular mortality, with SIRI showing superior predictive performance. This study underscores the prognostic utility of SII and SIRI in patients with MIS and provides valuable insights into their roles in mortality risk assessment.Keywords
This publication has 52 references indexed in Scilit:
- Association of systemic immune-inflammation-index with all-cause and cause-specific mortality among type 2 diabetes: a cohort study base on populationEndocrine, 2023
- Innate immunity drives pathogenesis of rheumatoid arthritisBiomedical Journal, 2021
- Age‐related differences in the immune response could contribute to determine the spectrum of severity of COVID‐19Immunity, Inflammation and Disease, 2021
- Global Burden of Cardiovascular Diseases and Risk Factors, 1990–2019JACC, 2020
- The possible pathophysiology mechanism of cytokine storm in elderly adults with COVID-19 infection: the contribution of “inflame-aging”Inflammation Research, 2020
- Neutrophil to lymphocyte ratio predict mortality and major adverse cardiac events in acute coronary syndrome: A systematic review and meta-analysisClinical Biochemistry, 2018
- Non-alcoholic fatty liver disease is strongly associated with carotid atherosclerosis: A systematic reviewJournal of Hepatology, 2008
- Plasma sex steroid hormones and risk of developing type 2 diabetes in women: a prospective studyDiabetologia, 2007
- Sex Differences of Endogenous Sex Hormones and Risk of Type 2 DiabetesJAMA, 2006
- Definition, diagnosis and classification of diabetes mellitus and its complications. Part 1: diagnosis and classification of diabetes mellitus. Provisional report of a WHO ConsultationDiabetic Medicine, 1998